Elis: Q1 2016 revenues

Elis: Q1 2016 revenues

ID: 468484

(Thomson Reuters ONE) -


Puteaux, May 4, 2016


Q1 2016 revenues
Revenues up 8.9%
+11.0% excluding currency impact and +4.1% on an organic basis

* Good organic growth momentum in all geographies

* +2.6% in France with all segments posting growth
* +6.2% in Europe with Southern Europe continuing to drive growth
* +13.9% in Latin America driven by good performance in Healthcare and
price increases in Brazil
* Further M&A activity with 2 acquisitions in Germany and Brazil in January,
representing combined revenues of c. ?20 million on a full-year basis
* FY16 outlook confirmed

* Revenue: +6% (+3% organic, +4% M&A and -1% FX)
* EBITDA margin: -30 bps in France and further improvement in Europe and
Latin America


Commenting on the 2016 first quarter revenues, Xavier Martiré, CEO of Elis,
said:

"The 4.1% organic revenue growth delivered in Q1 was very satisfactory and in
line with our expectations. It reflects the Group's momentum in all its
geographies, especially Southern Europe and Latin America.
At the beginning of the year, Elis continued its expansion in Europe and Latin
America through two strategic acquisitions which strengthened the Group's
position in Germany and reinforced its leadership position in Brazil. These
acquisitions are in line with Elis' strategy of consolidating its geographic
platforms and should contribute to accelerating the Group's development.
This set of figures allows us to confirm our FY16 outlook for revenue and
margin."


-----------------------------------------------------------------
Q1 revenues (EUR million) 2016 2015 Reported Organic
growth growth
-----------------------------------------------------------------




Trade & Services 84.8 83.1 2.1% 2.1%

Hospitality 66.9 62.2 7.4% 7.4%

Industry 47.1 46.7 0.9% 0.9%

Healthcare 41.3 39.4 4.8% 4.8%

France(a) 234.0 228.2 2.6% 2.6%

Northern Europe 50.3 38.2 31.7% 2.6%

Southern Europe 33.5 28.9 16.0% 11.0%

Europe 83.8 67.0 25.0% 6.2%

Latin America 28.1 22.3 26.1% 13.9%

Manufacturing Entities 4.7 4.5 4.2% 5.6%
-----------------------------------------------------------------
Total 350.6 322.0 8.9% 4.1%
-----------------------------------------------------------------
(a) : After other items including rebates
Percentage change calculations are based on actual figures

France

Q1 revenue growth of +2.6% in France was entirely organic and showed
acceleration compared to Q4 2015. All segments were up in Q1:
* Revenues for Trade & Services grew +2.1% driven by good commercial growth
from the signing of new contracts,
* Revenues for the Hospitality segment delivered solid growth of +7.4% on the
back of the roll-out of large contracts, as well as some non-recurring
calendar effects (Easter week in March vs in April in 2015 and the impact of
an additional day in February as 2016 is a leap year). This helped to offset
the residual impact from the terrorist attacks in November, which we
estimate at c. ?2mn in Q1, only in the Parisian region.
* Revenues for the Industry segment rose by 0.9% helped by new contracts
signed in 2015 with food processing clients and by good commercial growth.
Activity with existing clients was broadly stable,
* Revenues for the Healthcare segment grew by 4.8%, boosted by the
implementation of large contracts with both short-stay and long-stay
clients,

Europe

Q1 revenue growth in Northern Europe (+31.7%) was largely driven by the
acquisitions completed in April 2015, July 2015 and January 2016. Organic
revenue growth was +2.6%, with Switzerland and Germany, our main markets in the
region, delivering good growth thanks to the same calendar effects seen in
France and a good performance by the Hospitality segment.

Revenue in Southern Europe continued to be dynamic (+16.0%) in a favorable macro
environment with double-digit organic growth (+11.0%). This was again driven by
Spain, which grew revenues in all segments and benefited from the aforementioned
calendar effects.

Latin America

Q1 revenue growth increased +26.1% largely due to acquisitions we completed in
Brazil in July 2015 and in January 2016, and the acquisition of Albia in Chile
(consolidated since October 1(st )2015). Organic growth improved sharply in Q1,
at +13.9%. This was due to three main effects: (i) price increases,
(ii) strong activity from hospitals, laboratories and medical centers as a
consequence of epidemics that impacted Brazil during the summer and (iii) gains
of new contracts with large accounts. The depreciation of the Brazilian Real
strongly impacted our reported revenue growth with a -28.7% impact on revenues
in the region.


Investor and Analyst conference call

Speakers:
Xavier Martiré, CEO
Louis Guyot, CFO

Date: Wednesday, May 4 2016
9:00 am Paris time - 8:00 am London time

Webcast link (live and replay):
http://edge.media-server.com/m/p/x9ef5mmg
Webcast replay will be available for 1 year following the event.

Numbers to dial:
France: +33 1 76 77 22 22
France (toll-free): 0805 631 579
United Kingdom: +44 207 136 6283
United Kingdom (toll-free): 0800 279 4992
Code: 4251402#

Numbers for replay:
France: +33 1 74 20 28 00
United Kingdom: +44 203 427 0598
United States of America: +1 347 366 9565
Code for replay: 4251402#
Audio replay will be available for 1 week following the event.


Financial definitions

Organic growth in the Group's revenue is calculated excluding (i) the impacts of
changes in the scope of consolidation of "major acquisitions" and "major
disposals" in each of the periods under comparison, as well as (ii) the impact
of exchange rate fluctuations.


Forward looking statements

This release may contain some forward-looking statements. These statements are
not undertakings as to
the future performance of the Company. Although the Company considers that such
statements are based on reasonable expectations and assumptions at the date of
publication of this release, they are by their nature subject to risks and
uncertainties which could cause actual performance to differ from those
indicated or implied in such statements.
These risks and uncertainties include without limitation the risk factors that
are described in the Document de Base and in the 2015 Registration Document,
both registered in France with the French Autorité des marchés financiers.
Investors and holders of shares of the Company may obtain copy of these
documents from the Autorité des marchés financiers' website: www.amf-france.org
or from the Company's website:  www.corporate-elis.com/en/investor-relations
The Company does not have the obligation and undertakes no obligation to update
or revise any of the forward-looking statements.


Next information

H1 2016 results: July 26, 2016 (before market)


About Elis

Elis is a specialized multi-services group, leader in Europe and Latin America
for the rental and maintenance of flat linen, professional clothing, as well as
hygiene appliance and well-being services. With more than 21,000 employees
spread across 13 countries, Elis consolidated turnover in 2015 was ?1,415
million and consolidated EBITDA reached ?446 million. Benefiting from more than
a century of experience, Elis today services more than 240 000 businesses of all
sizes in the hotel, catering, healthcare, industry, retail and services sectors,
thanks to its network of more than 300 production and distribution centers and
13 clean rooms, which guarantees it an unrivalled proximity to its clients.


Contact

Nicolas Buron, Investor Relations Director - Phone: +33 1 41 25 46 77 -
nicolas.buron(at)elis.com



Elis - Q1 2016 revenues:
http://hugin.info/167809/R/2009482/743736.pdf



This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Elis via GlobeNewswire
[HUG#2009482]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  WaferGen Bio-systems Announces ICELL8(TM) Single-Cell System Placements at the European Molecular Biology Laboratory and Karolinska Institutet Pöyry PLC: Interim Report 1 January - 31 March 2016
Bereitgestellt von Benutzer: hugin
Datum: 04.05.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 468484
Anzahl Zeichen: 9950

contact information:
Town:

Puteaux-la-Défense



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 256 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Elis: Q1 2016 revenues"
steht unter der journalistisch-redaktionellen Verantwortung von

Elis (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Elis



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z